Mitsui Chemicals to acquire JSR for US$11.6 billion, targeting semiconductor materials growth

Mitsui Chemicals' $11.6B absorption of JSR is not routine M&A—it is the irreversible compression of Japan's "Big Four" semiconductor materials oligopoly into a "Big Three." JSR holds core EUV photoresist and CMP slurry formulations; Mitsui brings upstream organic synthesis and specialty resin capacity. The strategic logic is welding molecular design to scaled manufacturing on a single line, directly eroding TOK's and Shin-Etsu's differentiation at leading-edge nodes. Technically, the combined entity will command a fuller stack—photoresist, anti-reflective coatings, wet-chemistry cleans—at 2nm and below, forcing TSMC and Samsung to re-run qualification cycles. Yet the geopolitical arithmetic is uncomfortable: with EUV photoresist suppliers dropping from four to three, any single-point disruption (echoing Japan's 2019 export controls on South Korea) will push fabs from dual-sourcing to triple-sourcing, structurally raising compliance costs chain-wide. Competitively, Shin-Etsu will likely accelerate vertical integration in photoresist and packaging materials. Entegris and Merck, armed with CHIPS Act subsidies, will push "materials-plus-equipment" bundling in North America to displace Japanese suppliers from U.S. advanced-node supply chains. The real 18-month tail risk is not in P&L but in patent cross-licensing: the merged EUV formulation pool plus Mitsui's resin IP creates a new moat that permanently raises the marginal cost for non-Japanese entrants into advanced lithography materials.